# IgG4-Related Disease: A Case Series Highlighting Diverse Clinical Manifestations and Treatment Outcomes

**Authors:** Thanda Aung, Kaitlin Eblen, Gregory A Fishbein

PMC · DOI: 10.7759/cureus.94790 · Cureus · 2025-10-17

## TL;DR

This paper presents three cases of IgG4-related disease with varied symptoms and successful treatment using rituximab, highlighting the importance of accurate diagnosis.

## Contribution

The study contributes by showcasing diverse clinical presentations and effective treatment outcomes in IgG4-related disease.

## Key findings

- Three patients with IgG4-RD showed varied symptoms including gland swelling and lymphadenopathy.
- All patients responded well to rituximab treatment, showing clinical and radiological improvement.
- The cases emphasize the need to consider IgG4-RD in multisystem and atypical conditions.

## Abstract

IgG4-related disease (IgG4-RD) is a systemic immune-mediated fibroinflammatory condition characterized by tumor-like swelling of affected organs, lymphoplasmacytic infiltration enriched with IgG4-positive plasma cells, and variable degrees of fibrosis. We present three cases of IgG4-RD with diverse clinical presentations, highlighting the diagnostic challenges and management approaches. Our cases include a 45-year-old female with lacrimal and salivary gland involvement mimicking Sjögren's syndrome, a 77-year-old male with pancreatic mass, mesenteric vasculitis, and intra-abdominal lymphadenopathy initially suspected as pancreatic cancer, and a 75-year-old male with diffuse lymphadenopathy, initially thought to be lymphoma. All patients were successfully treated with rituximab with good clinical and radiological responses, emphasizing the importance of considering IgG4-RD in the differential diagnosis of conditions with multisystem involvement and atypical presentations.

## Linked entities

- **Diseases:** IgG4-related disease (MONDO:0017287), pancreatic cancer (MONDO:0005192), lymphoma (MONDO:0003659)

## Full-text entities

- **Diseases:** pancreatic mass (MESH:D010195), fibrosis (MESH:D005355), lymphoma (MESH:D008223), mesenteric vasculitis (MESH:D014657), swelling (MESH:D004487), pancreatic cancer (MESH:D010190), intra-abdominal lymphadenopathy (MESH:D000082122), IgG4-RD (MESH:D000077733), tumor (MESH:D009369), diffuse lymphadenopathy (MESH:D008228), Sjogren's syndrome (MESH:D012859)
- **Chemicals:** rituximab (MESH:D000069283)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12619937/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12619937/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12619937/full.md

---
Source: https://tomesphere.com/paper/PMC12619937